Cystic Fibrosis: A Risk Condition for Renal Disease

被引:14
|
作者
Santoro, Domenico [1 ]
Postorino, Adele [1 ]
Lucanto, Cristina [2 ]
Costa, Stefano [2 ]
Cristadoro, Simona [2 ]
Pellegrino, Salvatore [2 ]
Conti, Giovanni [2 ]
Buemi, Michele [1 ]
Magazzu, Giuseppe [2 ]
Bellinghieri, Guido [1 ]
机构
[1] Univ Hosp AOU G Martino, Dept Clin & Expt Med, Unit Nephrol & Dialysis, Messina, Italy
[2] Univ Hosp AOU G Martino, Unit Pediat Gastroenterol & Cyst Fibrosis, Unit Pediat Nephrol, Messina, Italy
关键词
AA AMYLOIDOSIS; SYSTEMIC AMYLOIDOSIS; REGULATOR CFTR; KIDNEY;
D O I
10.1053/j.jrn.2017.05.006
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: Cystic fibrosis (CF) is the most common autosomal recessive disease affecting the Caucasian population, with a birth incidence ranging between 1:2,500 and 1:1,800. It is caused by mutations in the CF transmembrane regulator gene which is localized on 7 chromosomes. Renal disease is reported as a relatively rare complication in adult patient with CF. We evaluated proteinuria and chronic renal failure (CRF) in a population of patients with CF. Methods: A retrospective study was carried out in a referral center for CF at University of Messina in Italy. We identified all patients with renal disease, characterized by proteinuria and/or CRF, during the period 2007 to 2012 and reviewed their medical records to assess influence on renal disease of genotype, number of pulmonary exacerbation, pancreatic insufficiency, pulmonary function, CF-related diabetes, and antibiotics courses. Results: From a population of 77 adult patients with CF, we identified 9 patients with proteinuria (11.7%), and 11 patients (14.28%) with CRF. Mean age was 35.6 (+5.1 standard deviation) years, 55% were female and 33% had diabetes mellitus. Renal biopsy was performed in 3 patients because of nephrotic syndrome in 1 patient and proteinuria with renal failure in the other 2 patients. Renal amyloidosis was disclosed in 2, whereas IgA nephropathy in 1 patient. The Delta F508 mutation in homozygosis was present in 44% of patients with proteinuria (vs. 27% of our CF population, relative risk 2.07), whereas genotype Delta F508/N1303K in 22%. Delta F508 allele mutation was present in 77.7% of proteinuric patients. Conclusions: Our study shows a higher prevalence of renal disease in patients with CF, than was previously described. The main reason may be related to increased life expectancy because of better management. Moreover, patients with Delta F508 homozygosis had higher risk of proteinuria. (C) 2017 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:470 / 473
页数:4
相关论文
共 50 条
  • [1] Renal disease in cystic fibrosis
    Malaga, S.
    Campuzano, S.
    Diaz, J. J.
    Bousono, C.
    Rodriguez, M.
    [J]. PEDIATRIC NEPHROLOGY, 2008, 23 (08) : 1386 - 1386
  • [2] A review of renal disease in cystic fibrosis
    Nazareth, Dilip
    Walshaw, Martin
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (04) : 309 - 317
  • [3] RENAL DISEASE IN ADULT PATIENTS WITH CYSTIC FIBROSIS
    Postorino, Adele
    Costa, Stefano
    Cristadoro, Simona
    Magazzu, Giuseppe
    Bellinghieri, Guido
    Savica, Vincenzo
    Buemi, Michele
    Santoro, Domenico
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 399 - 399
  • [4] Cystic fibrosis and renal disease: A case report
    Al-Shawwa B.A.
    Rao A.R.
    [J]. Journal of Medical Case Reports, 1 (1)
  • [5] Cystic fibrosis is a risk factor for celiac disease
    Walkowiak, Jaroslaw
    Blask-Osipa, Anna
    Lisowska, Aleksandra
    Oralewska, Beata
    Pogorzelski, Andrzej
    Cichy, Wojciech
    Sapiejka, Ewa
    Kowalska, Miroslawa
    Korzon, Michal
    Szaflarska-Poplawska, Anna
    [J]. ACTA BIOCHIMICA POLONICA, 2010, 57 (01) : 115 - 118
  • [6] Risk Factors for Hepatic Steatosis in Cystic Fibrosis Are Distinct from Risk Factors for Cystic Fibrosis Liver Disease
    Ayoub, Fares
    Lascano, Jorge
    Morelli, Giuseppe
    [J]. HEPATOLOGY, 2017, 66 : 663A - 664A
  • [7] Periodontal condition and periodontal risk assessment in adult patients with cystic fibrosis
    Pawlaczyk-Kamienska, Tamara
    Borysewicz-Lewicka, Maria
    Sniatala, Renata
    [J]. ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2020, 27 (02) : 235 - 239
  • [8] Liver disease in Cystic Fibrosis - prevalence and risk factors
    Schibli, S.
    Rose, J.
    Durie, P.
    Ellis, L.
    Tullis, E.
    Kovesi, T.
    Corey, M.
    [J]. SWISS MEDICAL WEEKLY, 2006, 136 : 14S - 14S
  • [9] Liver disease in cystic fibrosis: prevalence and risk factors
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 (4): : 165 - 165
  • [10] Risk factors for liver disease in cystic fibrosis (CF).
    Rigby, AS
    Pirzada, OM
    Taylor, CJ
    McGaw, J
    Evans, S
    Tanner, MS
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 213 - 213